Brazil’s medical cannabis industry entered a new chapter on May 4, 2026. After seven years under the provisional framework of RDC 327/2019, ANVISA’s…
Read More
Nova Era da Cannabis no Brasil: RDC 1.015 da ANVISA Entra em Vigor e Transforma o Maior Mercado de Cannabis Medicinal da América Latina
A indústria de cannabis medicinal do Brasil entrou em um novo capítulo em 4 de maio de 2026. Após sete anos sob o marco regulatório provisório da RDC 327/2019,…
Read More Portugal’s Cannabis Exports Triple: 42 Tonnes to Germany and Growing as Europe’s Processing Hub
Portugal shipped 55,164 kg of medical cannabis to Germany in 2025 â�� up from 17,230 kg in 2024, a **220% year-over-year increase**. In the first three…
Read More UK Medical Cannabis Prescriptions Surge 262%: 80,000 Patients and a GBP 500M Private Market
Seven years after the UK legalised cannabis-based products for medicinal use (CBPMs), the numbers are no longer incremental. Between 2022 and 2024, the total…
Read More Poland: Europe’s Quiet Cannabis Giant with 105,000 Patients and 5 Tonnes Dispensed in 2025
When most analysts discuss European cannabis, the conversation defaults to Germany’s scale, the UK’s private clinics, or the Czech Republic’s new adult-use…
Read More
Saint Lucia Selects GrowerIQ to Power National Cannabis Traceability Programme
Saint Lucia’s Regulated Substances Authority selects GrowerIQ through formal RFP to build national seed-to-sale traceability platform. Second Caribbean nation after Barbados.
Read More